Home Business Theralogix Launches TheraHemp, the First Enhanced-Absorption CBD Supplement to Achieve Certification by...

Theralogix Launches TheraHemp, the First Enhanced-Absorption CBD Supplement to Achieve Certification by NSF International

892
0
Theralogix

Theralogix, a nationally recognized nutritional science company, announced this week the launch of TheraHemp™, the first enhanced-absorption CBD supplement to be independently tested and certified for content accuracy and purity by NSF® International. TheraHemp successfully completed the rigorous testing and certification process to ensure content accuracy and purity by the public health organization, NSF International.

Commercial production of hemp and CBD products has remained unregulated despite consumer interest, therefore leaving consumers uncertain about the content and purity of many products. NSF International certification assures consumers TheraHemp’s THC content is non-detectable at 100 ppm (0.01%) and contains the exact amount of CBD shown on the label. This is particularly important for individuals subject to drug testing including competitive athletes, first responders, and many individuals holding commercial driver’s licenses. 

TheraHemp is formulated with VESIsorb, a patented emulsification agent that enhances absorption and bioavailability. By mimicking the body’s natural process of fat digestion, VESIsorb results in nearly 300% greater overall absorption of CBD. CBD with VESIsorb also results in three times faster absorption than its competitors, with peak CBD blood levels reached in one hour.

 Each TheraHemp softgel provides broad-spectrum hemp oil and is standardized to provide 20 mg of CBD along with 8 mg of beta-caryophyllene-enriched terpenes. TheraHemp is also dye-free and gluten-free. TheraHemp is available at $98 MSRP for a 60-count bottle. In addition, NSF certification ensures each CBD softgel contains the dose listed on the label, is certified gluten-free and does not contain contaminants. NSF certification is the best guarantee to ensure you are getting pure and accurate cannabinoid and terpene content. 

Theralogix was founded in 2002 by a team of physicians and scientists committed to developing evidence-based, independently certified micronutrient supplements. Theralogix products have been used in over a dozen clinical trials conducted by esteemed universities and research institutions across the United States. Theralogix has a full line of products for specialty uses including rheumatology, women’s health, urology, and fertility health. Each product has been approved by their Medical Advisory Board which is comprised of physicians, nationally reputed scientists, and faculty members from leading U.S. medical schools.  

Previous articleALCAZAR THEATRE SPOTLIGHTS “LEADING WOMEN IN CANNABIS” PANEL DISCUSSION
Next articleTop 10 CBD and Delta 8 Vape Cartridges and Disposable Pens
Dr. Mark Ratner completed his undergraduate studies at Cornell University, where he also did graduate work in Nutritional Biochemistry. Following graduate school, Dr. Ratner attended the Tulane University School of Medicine, and then continued with residency training in Adult and Pediatric Urology at the Tulane Hospital system. For over 30 years, his Washington, DC-based practice focused on male reproductive health. He has been an investigator for dozens of clinical trials, and served as the Director of Male Reproductive Medicine for one of the largest IVF practices in the country. Since stepping away from patient care in 2018, he has served as the Chief Science Officer for Theralogix, LLC. Over the years, Dr. Ratner has spoken at dozens national meetings, covering topics across a wide range of medical specialties including nutrition, male and female fertility, rheumatology, ob/gyn, urology and pain management.